Professional corporation

Amarin Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 1, 2023
Research, SMC, Medicare, Prescription, Risk, Forecasting, CVRR, Telephone, Health technology assessment, GAAP, HTA, Commercial, Marketing, Healthcare Improvement Scotland, Professional corporation, Investment, Patient, Hypertriglyceridemia, National Medical Products Administration, Conference, Organization, IPE, Medicaid, NMPA, File, Socialist Alternative (England, Wales & Scotland), ASEAN, Rare-earth element, Management, Pharmaceutical industry, Health insurance, Video game, Cryptocurrency, Bank, Amarin

-- Company to Host Conference Call Today at 8:00 a.m. ET --

Key Points: 
  • ET --
    DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced financial results for the quarter ended September 30, 2023 and provided an update on company operations.
  • “As we focus on demonstrating results that will drive shareholder value, there are reasons to be optimistic about the future of Amarin,” said Patrick Holt, President & CEO of Amarin.
  • U.S. product net revenue was $62.4 million in the third quarter of 2023, a decline of $2.2 million versus the second quarter of 2023, a decrease of 3% sequentially.
  • The company has provided these non-GAAP financial measures in addition to GAAP financial results because it believes that these non-GAAP adjusted financial measures provide investors with a better understanding of the company’s historical results from its core business operations.

Lexicon Strengthens Management Team With Two New Executives

Retrieved on: 
Tuesday, October 31, 2023
Knowledge, National Investor Relations Institute, Professional corporation, Bristol Myers Squibb, Melinta Therapeutics, Policy, AbbVie, Lexicon, Therapy, Ophthalmology, Actavis, Intercept, BS, Seton Hall University, Ozanimod, University, Amarin, Warner Chilcott, MBA, Ladenburg Thalmann, Alemtuzumab, Allergan, Business administration, Marketing, Wall Street, Watson Labs, Villalba v Merrill Lynch & Co Inc, Sclerosis, Heart failure, Intercept Pharmaceuticals, Pharmaceutical industry

THE WOODLANDS, Texas, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Matthew Cullen is joining the company as vice president of value and access, effective November 1, 2023, and Lisa DeFrancesco will join as head of investor relations and corporate strategy, effective November 13, 2023.

Key Points: 
  • Mr. Cullen brings Lexicon more than 35 years of industry experience in market access and sales leadership.
  • Before joining Lexicon, Matt served as vice president, value, access and policy at Apellis Pharmaceuticals where he led the market access launch of rare disease drug EMPAVELI® (pegcetacoplan) and ophthalmology drug SYFOVRE® (pegcetacoplan injection).
  • His responsibilities included pricing and contracting, payer strategy and marketing, corporate and strategic account management, field reimbursement, trade and distribution, and training.
  • Prior to Apellis, Mr. Cullen led strategic payer marketing and access teams at Bristol-Myers Squibb for ELIQUIS® (apixaban) and ORENCIA® (abatacept).

Amarin Appoints Jonathan Provoost Executive Vice President, Chief Legal & Compliance Officer

Retrieved on: 
Tuesday, October 31, 2023
Pace University School of Law, Business development, Intellectual property, State University of New York at Oswego, Chief, Lehigh University, Bristol Myers Squibb, Mallinckrodt, Professional corporation, General counsel, Patent, Management, Amarin, Chemistry

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Jonathan Provoost as the Company's new Executive Vice President, Chief Legal & Compliance Officer. He will join the Company on November 15.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Jonathan Provoost as the Company's new Executive Vice President, Chief Legal & Compliance Officer.
  • Mr. Provoost, who most recently served as Vice President, General Counsel and Chief Compliance Officer at Tris Pharma, Inc., brings more than 20 years of corporate legal experience, having served most of his career in large and medium-sized pharmaceutical companies.
  • Mr. Provoost’s broad experience in the legal profession includes serving as Chief Compliance Officer and General Counsel, management of intellectual property, general transactions, litigation, and various business activities.
  • Throughout Jonathan’s career he has enjoyed positions of increasing managerial responsibility, and most recently, served as Vice President, General Counsel and Chief Compliance Officer at Tris Pharma, Inc.

Lumentum to Acquire Cloud Light to Accelerate Data Center Speed and Scalability

Retrieved on: 
Monday, October 30, 2023
Technology, Engineering, Telecommunications, Manufacturing, Networks, Internet, Hardware, Data Management, Artificial Intelligence, Cloud, Wilson Sonsini Goodrich & Rosati, Professional corporation, History, DWDM, Morgan, Lewis & Bockius, Acquisition, LLP, Cloud computing, AI, Calendar, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., BofA Securities, Video game

Lumentum Holdings Inc. (NASDAQ: LITE) (“Lumentum”) and Cloud Light Technology Limited (“Cloud Light”) today announced that they have entered into a definitive agreement under which Lumentum will acquire Cloud Light with a transaction value of approximately $750 million, subject to certain adjustments.

Key Points: 
  • Lumentum Holdings Inc. (NASDAQ: LITE) (“Lumentum”) and Cloud Light Technology Limited (“Cloud Light”) today announced that they have entered into a definitive agreement under which Lumentum will acquire Cloud Light with a transaction value of approximately $750 million, subject to certain adjustments.
  • The acquisition of Cloud Light is expected to accelerate Lumentum’s push into the fastest growing segments of the multibillion-dollar opportunity for optical modules used in cloud computing data center infrastructure.
  • “With Cloud Light, we are making a strategic investment to significantly expand our opportunities in the cloud data center and networking infrastructure space,” said Alan Lowe, Lumentum president and CEO.
  • “Cloud Light provides us with the highest speed transceiver solutions at scale and complements our advanced component capabilities.

Revolution Foods Increases Focus on Serving Local Students and Communities

Retrieved on: 
Thursday, November 2, 2023
Meal, Food, Organization, Learning, Student, School, Professional corporation, San Fernando Valley, Fast food, Soft drink, Commerce

COMMERCE, Calif. , Nov. 2, 2023 /PRNewswire/ -- Revolution Foods, the leading vended meal provider for California schools, announces today its renewed focus and continued commitment to serving students on the West Coast. Recognizing the important role that nutrition plays in improved learning outcomes and lifelong positive eating habits, Revolution Foods is committed to making it easier for all schools to deliver on the promise of Universal School Meals. With its headquarters in Commerce, CA, the company is well-positioned to be a collaborative and progressive partner for California and Nevada schools and school districts.

Key Points: 
  • Revolution Foods operates one of America's top 20 "outsourced" K-12 kitchens.
  • "Revolution Foods is intent on developing a socially and financially sustainable model for good in school feeding," said Dominic Engels, CEO of Revolution Foods.
  • "El Milagro Baked Goods is delighted to partner with Revolution Foods to provide fresh locally crafted products to students across the state," commented Diana Gamez, General Manager.
  • Revolution Foods, alongside other major school districts and schools, lead the way in making a positive impact in delivering fresh food to students from kindergarten through high school.

Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent ethyl) and Subgroups from the REDUCE-IT Landmark Outcomes Trial to be Presented at the American Heart Association (AHA) Scientific Sessions 2023

Retrieved on: 
Thursday, October 26, 2023
CH.B, MB, Plasma, Health, DHA, SVP, History, Eicosapentaenoic acid, American Heart Association, Amarin, Diabetes, Research, Metabolic syndrome, EPA, Abadir Umar ar-Rida, Risk, IPE, Abstract, Professional corporation, AHA, Molina Healthcare, Patient, Cardiovascular disease, Pharmaceutical industry, Dietary supplement

This subgroup was almost exclusively comprised of patients with established cardiovascular disease.

Key Points: 
  • This subgroup was almost exclusively comprised of patients with established cardiovascular disease.
  • Lastly, an abstract describing the demographic/clinical characteristics of US patients taking icosapent ethyl, focusing on those with diabetes, will also be presented.
  • These and other new findings will be presented by a variety of international academic collaborators based on research or analyses supported by Amarin.
  • Featured Amarin-supported abstracts to be presented at AHA Scientific Sessions 2023 include:
    Michael Miller, Deepak L. Bhatt, Eliot A. Brinton, Terry A Jacobson et al...

 Amarin to Report Third Quarter 2023 Financial Results and Host Conference Call on November 1, 2023

Retrieved on: 
Thursday, October 19, 2023
Q&A, Professional corporation, Amarin, ET, Conference, Management

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss the Company’s third quarter 2023 financial results on Wednesday, November 1st, 2023 at 8:00 a.m.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss the Company’s third quarter 2023 financial results on Wednesday, November 1st, 2023 at 8:00 a.m.
  • Starting on October 19th at 8:00 am ET, all shareholders can submit questions by visiting: https://app.saytechnologies.com/amarin-2023-q3 .
  • The conference call with management will follow the release of the Company’s third quarter 2023 financial results in the pre-market hours.
  • Conference Call and Webcast Information:
    Access to the live call:
    Dial in within the United States: 877-545-0523

Agrology Receives Phase IIB Funding from the National Science Foundation (NSF)

Retrieved on: 
Wednesday, October 25, 2023
Science, Agriculture, Research, Natural Resources, Environment, Environmental Issues, Climate Change, Green Technology, National Science Foundation, Work, Carbon, Intellectual property, Entrepreneurship, R, Farmer, Professional corporation, Nitrous oxide, NSF, Pharmaceutical industry, Agrology

Agrology today announced that the company received $500,000 in Phase IIB Funding from the National Science Foundation (NSF) to further develop Agrology’s real-time soil carbon and nitrous oxide emission monitoring technology.

Key Points: 
  • Agrology today announced that the company received $500,000 in Phase IIB Funding from the National Science Foundation (NSF) to further develop Agrology’s real-time soil carbon and nitrous oxide emission monitoring technology.
  • America’s Seed Fund is powered by the National Science Foundation (NSF) and awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact.
  • Agrology was founded in 2019 with a highly-selective National Science Foundation SBIR Award.
  • Today, Agrology is a Public Benefit Corporation committed to protecting the economic viability of our farmers and the sustainability of our planet.

Enterprise Growth Engine Innventure Enters Agreement With Learn CW as It Heads Towards IPO

Retrieved on: 
Tuesday, October 24, 2023
Asset Management, Professional Services, Business, Finance, Security (finance), Education, NYSE, Securities and Exchange Commission of Pakistan, Acquisition, Learning, Sidley Austin, Management, Founders Fund, LLP, Traction, Professional corporation, BCA, Risk management, Cryptocurrency

Innventure LLC (“Innventure”), an enterprise growth engine, and Learn CW Investment Corporation , a publicly traded special purpose acquisition company (“Learn CW”) (NYSE: “LCW”) sponsored by CWAM LC Sponsor LLC, an affiliate of Learn Capital and Commonwealth Asset Management, announced today that they have entered into a business combination agreement (the “BCA”) that will result in Innventure becoming a public company.

Key Points: 
  • Innventure LLC (“Innventure”), an enterprise growth engine, and Learn CW Investment Corporation , a publicly traded special purpose acquisition company (“Learn CW”) (NYSE: “LCW”) sponsored by CWAM LC Sponsor LLC, an affiliate of Learn Capital and Commonwealth Asset Management, announced today that they have entered into a business combination agreement (the “BCA”) that will result in Innventure becoming a public company.
  • “The Innventure platform is a compelling variation on the classic venture capital model,” said Rob Hutter, CEO of Learn CW.
  • The Board of Managers of Innventure and the Board of Directors of Learn CW have each unanimously approved the transaction.
  • Vedder Price and Jones Day are acting as the legal advisors to Innventure, and Sidley Austin LLP is acting as legal advisor to Learn CW.

Illustrative Mathematics and Imagine Learning Expand Partnership to Empower More Students in Mathematics

Retrieved on: 
Wednesday, October 25, 2023
NCTM, Curriculum, DC, NAEP, Mathematics, RAND Corporation, Research, Imagine, Senior, Professional corporation, Student, Partnership, NCSM, IM, Tutoring, Management

TUCSON, Ariz., Oct. 25, 2023 /PRNewswire-PRWeb/ -- Illustrative Mathematics (IM), a nonprofit dedicated to creating a world where all learners know, use, and enjoy mathematics, announces the organization is expanding its partnership with Imagine Learning, the largest provider of digital curriculum solutions in the U.S.

Key Points: 
  • The fortified relationship with the Imagine Learning team will continue scaling the reach of the high-quality curriculum with the launch of Imagine IM, Imagine Learning's new edition of the Illustrative Mathematics curriculum, empowering even more students to learn grade-level mathematics and develop positive mathematical identities.
  • Imagine Learning will support its district partners with effective professional learning and ongoing implementation support.
  • Imagine Learning and Illustrative Mathematics are answering the call with engaging materials that meet students where they are and provide opportunities to learn grade-level mathematics.
  • Imagine IM is the next step in achieving our mission of giving all students equitable access to grade-level mathematics," said Bill McCallum , CEO and Co-Founder of Illustrative Mathematics.